Grants for Native American tribal organizations - Health

This funding opportunity supports U.S.-based researchers and organizations in developing non-addictive pain relief therapies to combat the opioid crisis, with a focus on advancing preclinical candidates toward clinical trials.

This funding opportunity supports researchers developing and testing strategies to prevent fetal alcohol spectrum disorders and improve interventions for affected individuals throughout their lives.

This funding opportunity supports research projects that explore how patients' beliefs and expectations about cancer treatment can improve symptom management, particularly for underserved populations facing unique challenges in care.

The "Research Experiences to Enhance Clinician-Scientists' Participation in NIDCDs Research" grant aims to support educational activities and hands-on research experiences that encourage clinicians, particularly those from diverse backgrounds, to pursue research careers in biomedical, behavioral, and clinical sciences, with a focus on areas relevant to the National Institute on Deafness and Other Communication Disorders (NIDCD).

This funding opportunity provides financial support to various organizations, including health centers and nonprofits, to implement evidence-based strategies that increase colorectal cancer screening rates among underserved populations aged 45 to 75.

This program provides financial assistance to state and local agencies, victim service organizations, and non-profits to support victims of terrorism and mass violence through compensation and crisis response services.

This funding opportunity supports researchers in developing and optimizing neurophysiological measures to improve the treatment development process for mental disorders in both humans and relevant animal species.

The "NCI National Clinical Trials Network - Network Lead Academic Participating Sites" grant is a funding opportunity from the National Cancer Institute for academic centers to provide scientific leadership and patient recruitment for large-scale, multi-institutional cancer clinical trials, with a focus on treatment trials, rare cancers, and underserved populations, offering up to $1.7 million per year for a six-year project period.

This grant provides preclinical support services to researchers developing innovative HIV therapies and addressing related health issues, enabling them to advance their drug development efforts.

This grant provides funding for researchers to conduct early-stage clinical trials aimed at improving treatments for patients with arthritis, musculoskeletal, or skin diseases.

This funding opportunity provides financial support to American Indian and Alaska Native tribes and organizations to enhance substance use prevention and behavioral health services in their communities.

This funding opportunity provides financial support for researchers and institutions to develop and optimize animal models that assess brain circuit engagement, aiming to improve therapeutic approaches for mental health conditions.

This funding opportunity supports interdisciplinary teams in developing innovative 3D tissue systems that model human aging processes for research and drug discovery.

The purpose of this Notice is to announce the intention of National Institutes of Neurological Disorders and Stroke (NINDS) to reissue RFA-NS-21-021 to solicit applications for research pursuing translational activities and small clinical studies to advance the development of low risk therapeutic and diagnostic devices for disorders that affect the nervous or neuromuscular systems. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. The NOFO is expected to be published in Spring 2024 with an expected application due date in Summer 2024. This NOFO will utilize the R61/R33 activity code. Details of the planned NOFO are provided below.

This funding opportunity provides $2 million to support innovative research projects focused on developing resources and strategies for preventing firearm injuries, targeting a wide range of eligible organizations including nonprofits, educational institutions, and government entities.

This funding opportunity supports large-scale clinical trials aimed at improving the diagnosis, treatment, and prevention of vision disorders, providing essential resources and services to a wide range of eligible organizations, including universities, nonprofits, and businesses.

The purpose of the Radiation Exposure Screening and Education Program is to improve the health outcomes and quality of life for populations at increased risk for the development of radiogenic cancers and/or disease resulting from exposure to radioactive materials through uranium mine industry work or fallout from nuclear arms testing. The United States conducted 227 above-ground and 828 below-ground nuclear weapons tests between July 1945 and November 1962. Many of the above-ground tests released radioactive material into the atmosphere. That material reached the ground as nuclear fallout. The dangers of radiation exposure were unknown at the time. Workers did not receive protection. People who lived near the test sites were not warned of potential dangers or told to evacuate. Workers and residents had radiation exposure from touching fallout on the ground, breathing polluted air, eating polluted foods, and drinking polluted water. People exposed to radiation generated by the nuclear weapons tests are at risk for certain cancers and other serious health problems.

This program provides funding to develop and sustain new residency training programs in rural areas, aiming to address physician shortages and improve healthcare access in underserved communities.

This funding opportunity supports collaborative research initiatives focused on Alzheimer's disease and related dementias in low- and middle-income countries, encouraging partnerships between local researchers and U.S. scientists to build research capacity and develop innovative prevention and management strategies.

This funding opportunity supports the creation of essential research resources for biomedical studies related to infectious diseases, immune disorders, and vaccine development, aimed at a wide range of public and private organizations.